The Optimal Extent of Resection for Patients With Stages I or II Breast Cancer Treated With Conservative Surgery and Radiotherapy
Frank A. Vicini(Radiation Oncology Institute), Jay R. Harris(Harvard University), Anthony Abner(Dana-Farber Brigham Cancer Center), Timothy J. Eberlein, William Silen(Beth Israel Deaconess Hospital), Stuart J. Schnitt(Brigham and Women's Hospital), James L. Connolly(Beth Israel Deaconess Medical Center), Abram Recht(Beth Israel Deaconess Medical Center)
Cited by 138
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k